Steven Prestrelski
CEO
Department of phd & MBA
Xeris
United States of America
Biography
Inventor of the Xeris platform technologies, Steve is an internationally recognized expert in drug formulation and delivery with over 20 years of product development experience. He was most recently Vice President of Pharmaceutical R&D at Amylin Pharmaceuticals. Previously, he was the Executive Director of the Bydureon® program at Amylin, having led this program from Phase 2 through global regulatory filings.
Research Interest
Pharmaceuticals & biotechnology